LMTK2 and early-onset autosomal dominant Alzheimer disease: Additionally, in the case of at least in LMTK2, reduced LMTK2 expression is an early pathological phenomenon in Alzheimer’s disease and early anomalies are generally believed to contribute the most to the disease pathogenesis.